The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
GSK (GSK) plc announced that the Food and Drug Administration has approved Penmenvy for use in individuals aged 10 through 25 years. The ...
NEW YORK CITY, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...
GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for ...
The FTSE 100 and European stocks were mixed at the open on Monday, as traders digest the potential of escalating tensions between European powers, Ukraine and Russia. London's pre ...
These latest developments come just a few weeks after DeepSeek's release of a lower-cost AI model rattled markets, as it sparked concerns about the level of spending by major US tech companies in this ...
US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake ...
GSK Pharma delivered a better-than-expected performance in Q3, largely driven by robust volume growth in the general medicine ...
AstraZeneca’s Enhertu (trastuzumab deruxtecan) emerged as the highest-selling new drug in India in 2024, generating Rs 58 ...
Enhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new ...
GSK said its five-in-one meningococcal vaccine Penmenvy was approved by the U.S. Food and Drug Administration. The British pharmaceutical company on Monday said the vaccine was authorized for use in ...
After years of limping along, the GSK share price has leapt 11% in one month. But one of America's richest investors is ...